CNIPA on Amending the Patent Examination Guidelines No 391 – The National Law Review
CNIPA on Amending the Patent Examination Guidelines No 391 The National Law Review
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Velos Media Signs CommScope as HEVC Patent Licensee – Business Wire
Velos Media Signs CommScope as HEVC Patent Licensee Business Wire
-
In: PATENT NEWS
Qualigen Therapeutics Announces Issuance of US Patent for Expanded Applications of ALAN Anticancer Platform Technology – PRNewswire
Qualigen Therapeutics Announces Issuance of US Patent for Expanded Applications of ALAN Anticancer Platform Technology PRNewswire
-
In: PATENT NEWS
Enertopia Acquires Patented Solar Energy Technology – PRNewswire
Enertopia Acquires Patented Solar Energy Technology PRNewswire
-
In: PATENT NEWS
COVID Vaccine Verification – Electronic And Secure Through First Ever, Patented VAX Passbook And Passcard Technology – PRNewswire
COVID Vaccine Verification – Electronic And Secure Through First Ever, Patented VAX Passbook And Passcard Technology PRNewswire
-
In: PATENT NEWS
Timber Pharma nabs new U.S. patent for TMB-001, shares up 9% – Seeking Alpha
Timber Pharma nabs new U.S. patent for TMB-001, shares up 9% Seeking Alpha
-
In: PATENT NEWS
Apple Wins a Patent for Palm ID Biometric Authentication that could be used on Future iDevices and Macs – Patently Apple
Apple Wins a Patent for Palm ID Biometric Authentication that could be used on Future iDevices and Macs Patently Apple
-
In: PATENT NEWS
The Long-Awaited Fourth Amendment to the Chinese Patent Law: An In-Depth Look – IPWatchdog.com
The Long-Awaited Fourth Amendment to the Chinese Patent Law: An In-Depth Look IPWatchdog.com
-
In: PATENT NEWS
vivo patents a foldable smartphone design with stylus – gizmochina
vivo patents a foldable smartphone design with stylus gizmochina
-
In: PATENT NEWS
PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders – GlobeNewswire
PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders GlobeNewswire